湿性年龄相关性黄斑变性的基于液体的预后评估：3型黄斑新生血管需要单独分析。 - Suppr

Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation.

作者信息

Sharma Ashish, Parachuri Nikulaa, Kumar Nilesh, Bandello Francesco, Kuppermann Baruch D, Loewenstein Anat, Regillo Carl, Chakravarthy Usha

机构信息

Lotus Eye Hospital and Institute, Coimbatore, TN, India

Lotus Eye Hospital and Institute, Coimbatore, TN, India.

出版信息

Br J Ophthalmol. 2021 Mar;105(3):297-298. doi: 10.1136/bjophthalmol-2020-318128. Epub 2020 Dec 8.

DOI:10.1136/bjophthalmol-2020-318128

PMID:33293272

Abstract

摘要

相似文献

Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation.湿性年龄相关性黄斑变性的基于液体的预后评估：3型黄斑新生血管需要单独分析。

Br J Ophthalmol. 2021 Mar;105(3):297-298. doi: 10.1136/bjophthalmol-2020-318128. Epub 2020 Dec 8.

Predictors of AMD treatment response.

Ophthalmology. 2012 Nov;119(11):2413-2414.e5. doi: 10.1016/j.ophtha.2012.06.056.

Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency.新生血管性年龄相关性黄斑变性的治疗负担：视力结果与抗血管内皮生长因子注射频率相关。

Ophthalmic Surg Lasers Imaging Retina. 2017 Oct 1;48(10):780-784. doi: 10.3928/23258160-20170928-01.

Individualizing the intravitreal anti-VEGF dosing regimen for long-term management of neovascular AMD.个体化玻璃体内抗血管内皮生长因子给药方案用于新生血管性年龄相关性黄斑变性的长期管理

Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):508-12. doi: 10.3928/23258160-20150521-01.

Five-year outcomes of a personalized pro re nata treatment regimen with anti-vascular endothelial growth factor for neovascular age-related macular degeneration.个性化按需治疗方案联合抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的五年疗效

Acta Ophthalmol. 2019 Feb;97(1):e131-e133. doi: 10.1111/aos.13840. Epub 2018 Oct 3.

EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.辅助局部多佐胺-噻吗洛尔治疗对血管内皮生长因子治疗抵抗的新生血管性年龄相关性黄斑变性患者的疗效。

Retina. 2019 Oct;39(10):1953-1958. doi: 10.1097/IAE.0000000000002293.

Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause.新生血管性年龄相关性黄斑变性中耐受视网膜下液的概念：在注射暂停前了解细则。

Br J Ophthalmol. 2021 Feb;105(2):149-150. doi: 10.1136/bjophthalmol-2020-317933. Epub 2020 Sep 26.

Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.视网膜下高反射物质对抗血管内皮生长因子的可变反应，通过光学相干断层扫描血管造影进行分类。

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2089-2096. doi: 10.1007/s00417-018-4121-7. Epub 2018 Sep 1.

Radial versus raster spectral-domain optical coherence tomography scan patterns for detection of macular fluid in neovascular age-related macular degeneration.用于检测新生血管性年龄相关性黄斑变性中黄斑区积液的放射状与光栅状光谱域光学相干断层扫描模式

Br J Ophthalmol. 2016 Apr;100(4):491-4. doi: 10.1136/bjophthalmol-2014-306561. Epub 2015 Aug 10.

Appointment Compliance in Patients With Diabetic Macular Edema and Exudative Macular Degeneration.糖尿病性黄斑水肿和渗出性黄斑变性患者的预约依从性

Ophthalmic Surg Lasers Imaging Retina. 2018 Mar 1;49(3):186-190. doi: 10.3928/23258160-20180221-06.

引用本文的文献

Imaging Histology Correlations of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration.新生血管性年龄相关性黄斑变性的视网膜内液影像学组织学相关性。

Transl Vis Sci Technol. 2023 Nov 1;12(11):13. doi: 10.1167/tvst.12.11.13.

[Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration].[玻璃体内注射布罗芦izumab治疗新生血管性年龄相关性黄斑变性后双侧闭塞性血管炎]

Ophthalmologe. 2022 Jan;119(1):75-78. doi: 10.1007/s00347-021-01323-6. Epub 2021 Feb 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献